4.3 Article

A 0/1h-algorithm using cardiac myosin-binding protein C for early diagnosis of myocardial infarction

期刊

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ehjacc/zuac007

关键词

Cardiac myosin-binding protein C; cMyC; Troponin I; Troponin T; Myocardial infarction; APACE

资金

  1. Swiss National Science Foundation
  2. European Union
  3. Swiss Heart Foundation
  4. University of Basel
  5. University Hospital Basel
  6. Abbott
  7. Brahms
  8. Beckman Coulter
  9. Quidel
  10. Ortho Clinical Diagnostics
  11. Roche
  12. Singulex
  13. Siemens
  14. Medical Research Council (London, UK) [G1000737]
  15. Guy's and St Thomas' Charity (London, UK) [R060701, R100404]
  16. British Heart Foundation (Birmingham, London) [TG/15/1/31518, FS/15/13/31320]
  17. UK Department of Health through the National Institute for Health Research Biomedical Research Centre
  18. NIHR clinical lectureship [CL-2019-17-006]

向作者/读者索取更多资源

Cardiac myosin-binding protein C (cMyC) has shown high diagnostic accuracy in the early detection of non-ST-elevation myocardial infarction (NSTEMI). Its dynamic release kinetics may enable a more effective 0/1h-decision algorithm compared to current ESC hs-cTnT/I algorithm.
Aims Cardiac myosin-binding protein C (cMyC) demonstrated high diagnostic accuracy for the early detection of non-ST-elevation myocardial infarction (NSTEMI). Its dynamic release kinetics may enable a 0/1h-decision algorithm that is even more effective than the ESC hs-cTnT/I 0/1 h rule-in/rule-out algorithm. Methods and results In a prospective international diagnostic study enrolling patients presenting with suspected NSTEMI to the emergency department, cMyC was measured at presentation and after 1 h in a blinded fashion. Modelled on the ESC hs-cTnT/I 0/1h-algorithms, we derived a 0/1h-cMyC-algorithm. Final diagnosis of NSTEMI was centrally adjudicated according to the 4th Universal Definition of Myocardial Infarction. Among 1495 patients, the prevalence of NSTEMI was 17%. The optimal derived 0/1h-algorithm ruled-out NSTEMI with cMyC 0 h concentration below 10 ng/L (irrespective of chest pain onset) or 0 h cMyC concentrations below 18 ng/L and 0/1 h increase <4 ng/L. Rule-in occurred with 0 h cMyC concentrations of at least 140 ng/L or 0/1 h increase >= 15 ng/L. In the validation cohort (n = 663), the 0/1h-cMyC-algorithm classified 347 patients (52.3%) as 'rule-out', 122 (18.4%) as 'rule-in', and 194 (29.3%) as 'observe'. Negative predictive value for NSTEMI was 99.6% [95% confidence interval (CI) 98.9-100%]; positive predictive value 71.1% (95% CI 63.1-79%). Direct comparison with the ESC hs-cTnT/I 0/1h-algorithms demonstrated comparable safety and even higher triage efficacy using the 0h-sample alone (48.1% vs. 21.2% for ESC hs-cTnT-0/1 h and 29.9% for ESC hs-cTnI-0/1 h; P < 0.001). Conclusion The cMyC 0/1h-algorithm provided excellent safety and identified a greater proportion of patients suitable for direct rule-out or rule-in based on a single measurement than the ESC 0/1h-algorithm using hs-cTnT/I.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据